Takeda Vaccines, Inc.

Hansi Dean

Jill Ann Livengood

Jackie Marks

Raman Rao

Holli Giebler

Sushma Kommareddy

Tatsuki Satou

Mark Lyons

Laurence De Moerlooze

Asae Shintani

Htay Htay Han

Gary Dubin

James Gifford

Hetal Patel

Whitney Baldwin

Claire Y H Kinney

The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.

Zika vaccines and immunogenic compositions, and methods of using the same

The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.

Method for inactivating zika virus and for determining the completeness of inactivation

The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of manufacture, formulation, testing, and uses thereof.

Method for inactivating Zika virus and for determining the completeness of inactivation

Growing community of inventors

Cambridge, MA, United States of America

Hansi Dean